[Corrigendum] Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury

Mol Med Rep. 2022 Jul;26(1):241. doi: 10.3892/mmr.2022.12757. Epub 2022 Jun 1.

Abstract

Subsequently to the publication of this paper, the authors have noticed that Fig. 5 was published with inadvertent errors; essentially, the y‑axis label in Fig. 5D should have read "TNF‑α" instead of "IL‑1β" and conversely, in Fig. 5E, the y‑axis label should have read "IL‑1β" instead of "TNF‑α". The revised version of Fig. 5, with Figs. 5D and E now labelled correctly, is shown below. Note that these errors did not significantly affect either the results or the conclusions reported in this paper, and all the authors agree to this corrigendum. Furthermore, the authors thank the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 24: 795, 2021; DOI: 10.3892/mmr.2021.12435].

Keywords: acute kidney injury; exosome; microRNA‑1184.

Publication types

  • Published Erratum